Microfluidic Devices Market Size PowerPoint PPT Presentations

Global Microfluidic Devices Market is estimated to reach $14.3 Billion by 2024; growing at a CAGR of 22.5% from 2016 to 2024. Microfluidic involves flow of liquid within micro-sized channels.

Global Microfluidic Devices Market size is projected to be valued $14 Billion by 2024; with a CAGR of 22.3% from 2017 to 2025. Microfluidics is an evolving scientific field with numerous analytical applications and commerci

Microfluidic Devices Market Share And Trends Analysis By Industry, Material, Application And Region - Forecast 2027

Microfluidics Market size is estimated to reach US$ 43,398.7 million by 2027; it is estimated to grow at a CAGR of 17.9% from 2019 to 2027.

Medical Microfluidic Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Microfluidic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Microfluidic devices are referred to as lithographic devices utilized for the diagnosis or analysis of small volumes of fluids to perform the chemical, physiological and biological procedures. Microfluidics devices are gaining popularity across extensive range of diagnostic applications because of need of extremely low quantity of samples and efficiency in data interpretation in comparison to the traditional laboratory equipment.

The Global And China Microfluidic Devices Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Microfluidic Devices industry.

According to our new research study on “Micropump Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, material, application, end-user,” the market is expected to reach US$ 5,172.86 million by 2028 from US$ 1,553.01 million in 2021. A non-mechanical micropump employs forces directly on a liquid and have a limited flow rate, slower response compared to mechanical micropumps. However, they have shown to be very useful in drug delivery applications owing to their low power consumption. Non-mechanical micropumps are commonly used in micro devices because they can take advantage of physical properties of fluids when the volumes decrease to the micro-size and smaller.

The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.

Widefield Imaging Systems Market: Japan Regional Market Projected to Witness 2.1X Growth in Terms of Revenue over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The growing incidence of cardiovascular diseases and the technological developments in interventional cardiology devices are driving the demand of the market.

Market Size – USD 20.14 Billion in 2021, Market Growth – at a CAGR of 16.1%, Market Trends – Increasing application of microfluidic platforms in various healthcare industries

The microfluidics market is expected to witness market growth at a rate of 23.42% in the forecast period of 2022 to 2029. Data Bridge Market Research report on microfluidics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.

The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Biochips are miniaturized medical devices used within molecular laboratories to conduct simultaneous biochemical reactions. These devices can rapidly screen multiple biological analytes for several applications like disease diagnosis and identification of hazardous biological agents existing in systems. Their design is based on microarray and microfluidic technologies. Among the two, digital microfluidic biochip has surfaced as a highly efficient chip and has gained huge traction in the biochemical industry. Full Report: https://www.kbvresearch.com/biochips-market/

Microfluidics is a medical approach involving the precise control of small fluid samples for medical analysis. The sample sizes in microfluidics range from microliters to picolitres. At such low volumes, the transportation of fluid is governed significantly by its mass.

Microfluidic Sensors market size was valued at $1.4 billion in 2020, and it is estimated to grow at a CAGR of 6.9% during 2021-2026.

Global paper diagnostics market size is expected to reach $14.49 Bn by 2028 at a rate of 9.7%, segmented as by product, dipsticks, lateral flow assays, paper based microfluidics

Market Size – USD 9.51 billion in 2019, Market Growth - CAGR of 13.2%, Market Trends – Advancements in device technology.

The global microfluidics market size reached US$ 20.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2027, exhibiting a CAGR of 16.47% during 2022-2027. More info:- https://www.imarcgroup.com/microfluidics-market

According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market

The report Microfluidics Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market

[316 Pages Report] The Digital PCR market size is projected to reach $7.6 billion by 2025, at a CAGR of 9.0% between 2020 and 2025.

The Global Microfluidics Market report 2018-2024, has been prepared By Axiom Market Research & Consulting, based on a deep market analysis with inputs from industry experts. This report covers market landscape, strategies, merger & acquisition, size, key competitors, company profiles, progressive technological advancement, and expansion of production, segmentation, production, revenue and its growth prospects for the upcoming years.

Browse Complete Organ-On-Chips Global Opportunities And Strategies Market Report At: https://www.thebusinessresearchcompany.com/report/organ-on-chip-market

The organ-on-chip market consists of sales of organs-on-chips by entities (organizations, sole traders and partnerships) that manufacture organs-on-chips used for drug development, toxicity testing, and personalized medicine research. Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers containing multiple live human cells in a 3D culture that simulate key physiological functions of body organs. Organs-on-chips that mimic the organ level physiology of humans are a promising alternative to animal models.

Read here the latest updates on the U.S. BIOCHIP PRODUCT & SERVICES MARKET ANALYSIS published by CMI team.

he global market for veterinary diagnostic is estimated to progress at 7.71% CAGR throughout 2019-2027 and will generate revenue of $5,129 million by the end of 2027. The heavy demand for livestock products is partly responsible for the steady increase in market growth over the years.Know more @ https://www.inkwoodresearch.com/reports/north-america-veterinary-diagnostics-market/

The Global And China Microfluidic Device Pumps Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Microfluidic Device Pumps industry.

Request for an in-depth table of contents for this report @ https://www.gminsights.com/request-toc/upcoming/344 BioMEMS or bio-medical micro electro mechanical systems market has emerged as a division of MEMS devices for applications in medical micro devices and biomedical research. It offers various benefits such as it improves medical device performance for the patient and offers competitive advantages to system manufacturers.

With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach more than US$ 3,000 Mn in revenue and is estimated to grow 3.9x by 2026 end as compared to that in 2016. The point of care testing segment is the largest segment among the different application segments in the global microfluidics market, which was estimated to create close to US$ 1,000 Mn or 33.2% share of the total market in 2016. This segment is anticipated to register a CAGR of 14.5% over the forecast period.

Lab-On-a-Chip Market report segments global market by application, end-user, product, and technology – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017-2025

The synthetic biology market is expected to exceed more than US$38 billion by 2020.

Hyperbaric oxygen therapy (HBOT) devices are used for delivering pure oxygen (100%) to tissues in the body under higher atmospheric pressure. Atmospheric pressure in hyperbaric oxygen chambers or devices is increased from one to three times higher than normal atmospheric pressure which in turns fight bacteria and also stimulates the release of a substance called growth factors and stem cells promoting healing.

The global microfluidic devices market size was estimated to be US$ 13 billion in 2019 and is expected to grow at a CAGR of 10.8% through 2030. Microfluidic devices have emerged as a convenient and efficient solution for high throughput and low volume analysis of biochemical fluids. The demand for microfluidic devices is primarily driven by the rising adoption of point-of-care devices for efficient and quick assessment of wide range of medical conditions.

... Market size expectations Companies currently in Microfluidics market space: Microfluidics: Critical market segments Slide 9 NIST technology ...

Point-of-care (POC) diagnostics or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours.

According to the latest research report by IMARC Group, The global biochips market size reached USD 22.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 76.0 Billion by 2033, exhibiting a growth rate (CAGR) of 13.02% during 2025-2033. More Info:- https://www.imarcgroup.com/biochips-market

BioMEMS assimilate miniature sensors, actuators, micro-optics, microfluidics, and structural elements with computation and controls for application in the healthcare sector. Microsystems are used in the healthcare sector for numerous applications. These devices improve the performance of medical devices by providing a competitive advantage to medical device manufacturers. For instance, the use of accelerometers has improved the treatment of cardiac diseases. Another instance being the use of MEMS and nanotechnology to improve drug delivery. Global BioMEMS and Microsystem Market in the Healthcare sector to grow at a CAGR of 25.1% over the period 2014-2019. Read more details @ http://www.bigmarketresearch.com/global-biomems-and-microsystem-in-healthcare-2015-2019-market

According to the latest research report by IMARC Group, The global PMMA microspheres market size reached US$ 356.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 803.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.16% during 2024-2032. More Info:- https://www.imarcgroup.com/pmma-microspheres-market

The Business Research Company offers paper diagnostics market research report 2023 with industry size, share, segments and market growth

Micro-Electro-Mechanical System (MEMS) Market by Sensor Type (Inertial, Pressure, Microphone, Micxrospeaker, Environmental Sensor, Optical Sensor), Actuator Type(Optical, Inkjet Head, Microfluidics and RF), Vertical and Region

According to the latest research report by IMARC Group, The global biochips market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. More Info:- https://www.imarcgroup.com/biochips-market

According to the latest research report by IMARC Group, The global organ-on-chip market size reached US$ 61.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 541.8 Million by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032. More Info:- https://www.imarcgroup.com/organ-on-chip-market

According to the latest research report by IMARC Group, The global automotive actuators market size reached US$ 28.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 44.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. More Info:- https://www.imarcgroup.com/automotive-actuators-market

Micro-Electro-Mechanical Systems (MEMS) Market by Sensor Type (Inertial, Pressure, Microphone, Environmental, and Optical), Actuator Type (Optical, Inkjet Head, Microfluidics, and RF), Vertical, and Geography - Global Forecast to 2022

The Global Microfluidic Device Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Microfluidic Device industry.

According to the latest research report by IMARC Group, The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. More Info:- https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market

The application of microfluidic technologies and devices has been steadily ... A. F18 solution comes from a cyclotron, where 18F fluoride is produced via the ...

The rising incidence of hydrocephalus and increasing use of shunting procedures are driving the demand for the market.

The global medical device contract manufacturing market is anticipated to grow at a double digit CAGR during the forecast period. Medical device contract manufacturing organization provide services to outsource manufacturing of devices that enables original equipment manufacturers (OEMs) to reduce cost of product, product packaging and transport of product.

Increasing investment in R&D in molecular diagnostics, new product development, and rising prevalence of targeted diseases are some key factors driving market revenue growth.

Molecular Diagnostics in Cancer Testing @ http://www.reportsnreports.com/reports/75216-molecular-diagnostics-in-cancer-testing.html The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.

The global automated blood collection market size was USD 1.08 Billion in 2021 and is expected to register a revenue CAGR of 7.1% during the forecast period, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by factors such as growing public awareness about advantages that automated blood collection methods offer over manual blood collection techniques, ongoing demand for blood in hospitals, nursing homes, and ambulatory care facilities, rising rates of traffic accidents and trauma cases globally, and rising surgical rates.